货号:GS40791
Vilobelimab (IFX-1) is an investigational monoclonal antibody that specifically targets the complement activation fragment C5a (also known as anaphylatoxin C5a). It is designed to block the pro-inflammatory effects of C5a, with its most advanced clinical development focused on treating severe inflammatory conditions, such as severe COVID-19 and hidradenitis suppurativa.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
迈思生物